[Benign intracranial hypertension as a secondary effect of treatment with a biosynthetic growth hormone].
Bermúdez de la Vega
J A
JA
Departamento de Pediatría, Hospital Universitario Virgen Macarena, Sevilla.
Martínez Martínez
J J
JJ
Fernández Fiscer
P
P
González Hachero
J
J
D002648:Child; D004359:Drug Therapy, Combination; D013006:Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007018:Hypopituitarism / Q000150:complications / Q000188:drug therapy; D008297:Male; D011559:Pseudotumor Cerebri / Q000139:chemically induced* / Q000175:diagnosis; D013974:Thyroxine / Q000008:administration & dosage
D013006:Growth Hormone; D013974:Thyroxine